Clinical Trials
2 trialsNCT07102940 2026-02-20
Efti in Patients With Hormone Receptor Positive/HER2-neg Breast Cancer
George Washington University
Phase 2 Not yet recruiting
NCT03307785 2025-11-25
Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042
Tesaro, Inc.
Phase 1 Completed